Baroreflex sensitivity in patients with chronic heart failure: the clinical significance and impact of therapy
Nepoklonov, M.V.; Rogoza, A.N.; Skvortsov, A.A.; Gorieva, S.B.; Tereshchenko, S.N.
Terapevticheskii Arkhiv 82(12): 73-80
2010
ISSN/ISBN: 0040-3660 PMID: 21516745 Document Number: 646840
The review deals with the baroreflex regulation of circulation in chronic heart failure (CHF). The pathophysiological aspects of development of dysfunction of the baroreflex clinically estimated from its sensitivity are presented; the clinical value of this indicator is discussed in relation to the etiology of the underlying disease and clinicohemodynamic status. Data on the impact of some components of current therapy for CHF and nondrug treatments on the values of baroreflex sensitivity are shown.
Document emailed within 1 workday
Related Documents
Pitzalis, M.V. 2001: Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 2(7): 810-811Ko, Y.S.; Yang, S.Y.; Yian, W.K. 1990: Clinical significance of changes in the serum level of endogenous digitalis-like factor in patients with chronic congestive heart failure Zhonghua Nei Ke Za Zhi 29(1): 11-13; 59-60
Sasaki, T.; Kubo, T.; Miyamoto, T.; Komamura, K.; Honda, K.; Miyatake, K. 2001: Clinical significance of measuring inferior vena cava dimension in patients with acute exacerbation of chronic heart failure Journal of Cardiology 37(6): 309-313
Atherton, J.J.; Frenneaux, M.P.; Thomson, H.L. 1999: The role of diastolic ventricular interaction in abnormal cardiac baroreflex function in chronic heart failure Australian and New Zealand Journal of Medicine 29(3): 428-432
Belenkov, I.N.; Skvortsov, A.A.; Mareev, V.I.; Nasonova, S.N.; Sychev, A.V.; Narusov, O.I.; Baklanova, N.A.; Masenko, V.P. 2003: Clinical, hemodynamic and neurohumoral effects of long-term therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol Kardiologiia 43(10): 10-21
Tarantini, L.; Cioffi, G.; Opasich, C.; Di Lenarda, A.; Pulignano, G.; Del Sindaco, D.; De Feo, S.; Stefenelli, C.; Russo, P.; Catania, G. 2004: Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(6): 441-449
Wilczak, A.; Marciniak, K.; Kłapciński, M.ł; Rydlewska, A.; Danel, D.; Jankowska, E.A. 2013: Relations between combined oral contraceptive therapy and indices of autonomic balance (baroreflex sensitivity and heart rate variability) in young healthy women Ginekologia Polska 84(11): 915-921
Gasanov, I.; Rudyk, Y. 2019: Metoprolol Succinate: Genetic Aspects of Individual Sensitivity and Efficacy in Patients with Obesity and Chronic Heart Failure Georgian Medical News 286: 55-60
Rudyk, B.I.; Sabadyshin, R.A. 1992: The significance of the antioxidant properties of emoxipin in the combined treatment of patients with chronic heart failure Likars'ka Sprava 4: 25-28
Correia, J.; Silva, Fátima.Franco.; Roque, C.; Vieira, H.; Providéncia, Lís.Augusto. 2007: Impact of a specialized outpatient heart failure follow-up program on hospitalization frequency and functional status of patients with advanced heart failure Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 26(4): 335-343
Xue, C.; Yu, H.; Li, R.; Wo, J.; Cui, J.; Cheng, H.; Wang, H.; Guan, Q.; Suo, X.; Jia, R. 2003: Clinical significance of serum cardiac troponin T in patients with congestive heart failure Chinese Medical Journal 116(3): 469-471
Erdmann, E.; Beuckelmann, D.; Böhm, M.; Schwinger, H.G. 1992: Clinical aspects of differential drug therapy of chronic heart failure Zeitschrift für Kardiologie 81(Suppl 4): 97-103
Sheppard, R.J.; Racine, N.; Roof, A.; Ducharme, A.; Blanchet, M.; White, M. 2007: Heart rate recovery--a potential marker of clinical outcomes in heart failure patients receiving beta-blocker therapy Canadian Journal of Cardiology 23(14): 1135-1138
Iwata, A.; Miura, S.-i.; Nishikawa, H.; Kawamura, A.; Matsuo, Y.; Sako, H.; Kumagai, K.; Matsuo, K.; Saku, K. 2006: Significance of combined angiotensin Ii receptor blocker and carvedilol therapy in patients with congestive heart failure and arginine variant Journal of Cardiology 47(1): 1-7
Kikuchi, K.; Tanaka, H.; Gima, M.; Kashiwagi, Y.; Shida, H.; Kawamura, Y.; Hasebe, N. 2012: Abnormalities of magnesium (Mg) metabolism and therapeutic significance of Mg administration in patients with metabolic syndrome, type 2 diabetes, heart failure and chronic hemodialysis Clinical Calcium 22(8): 1217-1226
Kojima, R.; Nakatani, M.; Shirotani, T.; Ikeda, Y.; Kuniyoshi, T.; Tajiri, E.; Furuta, Y.; Inatome, T.; Yokoyama, M. 2001: Effects of home oxygen therapy on patients with chronic heart failure Journal of Cardiology 38(2): 81-86
Zahidova, K.K. 2018: Selection of Optimal Therapy at Correction of the Anemic Syndrome in Patients With Chronic Heart Failure Kardiologiia 2018(1): 25-31
Kuch, M.; Janiszewski, M.; Janiszewski, M.ł; Braksator, W.; Mamcarz, A.; Sadkowska, K.; Kuch, J.; Dłuzniewski, M.ła. 2006: Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 20(117): 285-288
Cao, X.-J.; Li, Y.-F.; Cao, F.-F.; Shi, S.-T.; Wang, G.; Zhang, L.-J.; Liu, F. 2010: Effects of immune modulation therapy on cardiac function in aged patients with chronic heart failure Zhonghua Xin Xue Guan Bing Za Zhi 38(8): 734-738
Kawashiro, N.; Matsuda, N.; Endo, Y.; Uchida, Y.; Kasanuki, H. 2006: Long-term outcome and tolerability of carvedilol therapy in Japanese patients with chronic heart failure Journal of Cardiology 47(5): 229-237